INTRODUCTION
Cutaneous neoplasms morphologically suggestive of a histiocytic lineage include heterogeneous, distinctive entities such as monocyte/macrophage lesions, Langerhans cell/dendritic cell lesions, fibrohistiocytic tumors, and CD30(+) anaplastic large cell lymphomas. Fibrohistiocytic tumors including dermatofibroma and atypical fibroxanthoma are mesenchymal neoplasms with a histiocytoid appearance. Langerhans cell/dendritic cell neoplasms and anaplastic large cell lymphomas express characteristic immunohistochemical markers for histiocytes and lymphoid cells, respectively. According to the current definition, only neoplasms derived from the monocyte/macrophage series are recognized as true histiocytic tumors.
In the skin, true histiocytic malignancies may manifest themselves as cutaneous involvement of generalized malignant histiocytosis (MH) or primary cutaneous true histiocytic sarcoma (PCTHS).
In general, the latter is recognized as a localized form of the former1-5. Here, we report a case of PCTHS which showed no relapse for 10 years, its indolent clinical behavior differing from the usual aggressive course of MH.
CASE REPORT
A 47-year-old woman, who was not from an HTLV-1-endemic area, presented with a three-week history of rapidly growing nodule on the right forehead without any antecedent episode such as insect bite or trauma. The lesion was 1.2cm in size, red and dome-shaped (Fig. 1) , and was movable without periosteal adhesion.
The patient lacked constitutional symptoms such as fever and wasting, and physical examination failed to demonstrate any enlargement of the superficial lymph nodes, liver and spleen.
There were no abnormal hematopoietic cells in the peripheral blood or bone marrow (aspiration and biopsy).
Other laboratory parameters were unremarkable.
Antibodies against both HTLV-1 and EB viruses were negative.
Image analyses including chest X-ray, Ga-scintigraphy, and abdominal CT showed no abnormalities.
The forehead lesion was locally excised, and no additional treatment was given.
The postoperative course was uneventful, and for 10 years the patient had no evidence of relapse at the primary site, metastasis or hematologic abnormality.
MATERIALS AND METHODS
The resected specimen was fixed in 10% buffered DNA was used directly for PCR amplification. The polymerase chain reaction was used to detect rearrangements of (1) the immunoglobulin heavy chain (IgH) gene using three VH primers (FR1c, FR2a and FR3a) and two JH primers (LJH and using eight V primers (V2/V8, V3, V4, V5, V9, V10, V11) and three J primers (J1.3/2.3, J1.1/2.1, J1.2)8, ain gene using five primers (V, D1, D2, J1 and J2)9.
RESULTS
Microscopically, the lesion consisted of a massive infiltration of large histiocytoid cells from the upper dermis into the tunica muscularis through the subcutaneous adipose tissue, and exhibited a circumscribed bottom-heavy pattern ( Fig. 2A) .
In addition, muscle fibers were destroyed by the infiltrating tumor cells (Fig. 2B) and atrophic without a clear Grenz zone. The tumor cells were accompanied by patchy reactive small lymphocytes in the dermis and the upper subcutis ( Fig 2C) . Almost all tumor cells were positive for CD68
(KP-1 and PG-M1) (Fig. 3A) and lysozyme (Fig.  3B) , and some were also positive for CD15 (Fig. 3C ). None were immunoreactive for CD1a, CD3, CD4, CD8, CD20, CD30, CD45, CD45RO, CD79a, S-100 protein, NSE, EMA, CEA, cytokeratins (CAM5.2 and AE1/AE3) or LMP. Ultrastructural examination clearly demonstrated nuclear foldings and abundant cytoplasm (Fig.  2D) . Although the ultrastructure was not well preserved, no tumor cells appeared to contain cerebriform nuclei, well developed rough endoplasmic reticulum or Birbeck granules.
In the genotypic analysis, there were no clonal Only the former are designated as "true" histiocytes.
Therefore, the diagnosis of true histiocytic neoplasm should be made only when characteristics of the monocyte/ macrophage series are strictly established. The cur rent criteria for true histiocytic sarcoma (THS)2,6,12,13 are as follows: 1) the tumor cells show histiocytoid features such as nuclear foldings, abundant cytoplasm and occasional phagocytosis; 2) they should be immunoreactive for two or more histiocyteassociated markers; 3) they lack reactivity for B celland T cell-specific markers; 4) they also lack Birbeck granules and reactivity for CD1a; 5) they are negative for CD30, which is a characteristic marker of anaplastic large cell lymphoma; 6) there is no evidence of immunoglobulin or T-cell-receptor gene rearrangement.
The above criteria are still controversial to some extent. First, evidence of phagocytosis is not always essential for diagnosis of THS5,6. Some investigators have also reported cases of CD30-positive and an abundant cytoplasm, although phagocytosis was apparently absent. The lesion also showed a destructive growth in the muscle layer and the cytologic atypia with numerous mitoses.
Immunohistochemically, the tumor cells were positive for CD68 (KP-1 and PG-M1) and lysozyme but negative for other lymphoid and epithelial markers. Electron microscopy failed to demonstrate the presence of Birbeck granules.
Clonal genes was not demonstrated. Therefore, the present tumor fulfilled the strict criteria of THS.
THS is very uncommon, occurring in lymph nodes as well as at extranodal sites such as the gastrointestinal tract, the liver, the kidneys, the lungs, the central nervous system, the bone marrow, the bones, the soft tissues and the skin. THS usually shows an aggressive clinical course and a poor prognosis2-5.
To our knowledge, 38 cases have been reported previously (Table) 4,5,12,13,17-22. Eight (21.1 %) of these cases initially involved the skin. Four were solitary, each one occurring in the supraclavicular, the abdominal, the back and the lumbosacral regions respectively, three had multiple or disseminated lesions, and one was of unspecified localization.
The patients ranged in age from 7 to 85 years (median: 60 years; mean: 53.4 years), and included five men and three women. During followup (0.5-96 months), which was possible in seven cases, four patients died from the tumor within 6 months, one died from infectious complications without tumor 96 months later, and two were alive without disease 10 months and 26 months later. Two of the three who lived more than 6 months were children aged 7 and 10 years. Secondary involvement of the skin was also described in seven cases (Table) .
Therefore, the skin is one of the most common sites of THS involvement (15 of 38 cases, or 39.5%).
There are several skeptical opinions on THS as a distinct entity.
Since THS is difficult to distinguish from monocytic leukemia (MoL) even by morphologic, cytochemical, immunocytochemical 
